Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Berke

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Experimental Medicine|December 1, 1972
Rejection of ascites tumor allografts. II. A pathway for cell-mediated tumor destruction in vitro by peritoneal exudate lymphoid cellsG Berke, K A Sullivan, B Amos
The Journal of Experimental Medicine|June 1, 1972
Rejection of ascites tumor allografts. I. Isolation, characterization, and in vitro reactivity of peritoneal lymphoid effector cells from BALB-c mice immune to EL4 leukosisG Berke, K A Sullivan, B Amos
Transplantation|October 1, 1973
An antigenic determinant of cytotoxic lymphocytesK A Sullivan, G Berke, D B Amos
Journal of Cellular Biochemistry|January 1, 1982
A common role for target cell histocompatibility antigens in both nonspecific and specific T lymphocyte-mediated cytolysisG Berke, V Hu, E McVey, et al.
Journal of the National Cancer Institute|December 1, 1973
Induction of cell-mediated immunity against leukemia EL4 in C57BL miceA Kemp, G Berke, J Crowell, et al.
Cellular Immunology|October 1, 1986
Maturation of cytolytic T lymphocytesM Moscovitch, Z Grossman, D Rosen, et al.
Cancer Research|December 1, 1973
Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cellsR F Todd, R D Stulting, G Berke
Cellular Immunology|December 1, 1973
Serum factors in lymphocyte proliferation. I. The requirement for serum in mixed lymphocyte reactionsS A Huber, G Berke, D B Amos
Science (New York, N.Y.)|August 4, 1972
Tumor immunity in vitro: destruction of a mouse ascites tumor through a cycling pathwayG Berke, K A Sullivan, D B Amos
Genome|October 1, 1995
Quantitative trait locus analysis of fatty acid concentrations in maizeR Alrefai, T G Berke, T R Rocheford
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Experimental Medicine|December 1, 1972
Rejection of ascites tumor allografts. II. A pathway for cell-mediated tumor destruction in vitro by peritoneal exudate lymphoid cellsG Berke, K A Sullivan, B Amos
The Journal of Experimental Medicine|June 1, 1972
Rejection of ascites tumor allografts. I. Isolation, characterization, and in vitro reactivity of peritoneal lymphoid effector cells from BALB-c mice immune to EL4 leukosisG Berke, K A Sullivan, B Amos
Transplantation|October 1, 1973
An antigenic determinant of cytotoxic lymphocytesK A Sullivan, G Berke, D B Amos
Journal of Cellular Biochemistry|January 1, 1982
A common role for target cell histocompatibility antigens in both nonspecific and specific T lymphocyte-mediated cytolysisG Berke, V Hu, E McVey, et al.
Journal of the National Cancer Institute|December 1, 1973
Induction of cell-mediated immunity against leukemia EL4 in C57BL miceA Kemp, G Berke, J Crowell, et al.
Cellular Immunology|October 1, 1986
Maturation of cytolytic T lymphocytesM Moscovitch, Z Grossman, D Rosen, et al.
Cancer Research|December 1, 1973
Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cellsR F Todd, R D Stulting, G Berke
Cellular Immunology|December 1, 1973
Serum factors in lymphocyte proliferation. I. The requirement for serum in mixed lymphocyte reactionsS A Huber, G Berke, D B Amos
Science (New York, N.Y.)|August 4, 1972
Tumor immunity in vitro: destruction of a mouse ascites tumor through a cycling pathwayG Berke, K A Sullivan, D B Amos
Genome|October 1, 1995
Quantitative trait locus analysis of fatty acid concentrations in maizeR Alrefai, T G Berke, T R Rocheford
Pageof 13